Literature DB >> 29730328

Poor Subpleural Perfusion Predicts Failure After Balloon Pulmonary Angioplasty for Nonoperable Chronic Thromboembolic Pulmonary Hypertension.

Yu Taniguchi1, Philippe Brenot2, Xavier Jais1, Carlos Garcia2, Jason Weatherald3, Olivier Planche4, Elie Fadel5, Marc Humbert1, Gérald Simonneau6.   

Abstract

BACKGROUND: Poor subpleural perfusion (PSP) in the capillary phase of pulmonary angiography predicts worse outcomes following pulmonary endarterectomy in operable chronic thromboembolic pulmonary hypertension (CTEPH). Balloon pulmonary angioplasty (BPA) has emerged as a treatment for nonoperable CTEPH. The goal of the present article was to assess the association between PSP and BPA failure.
METHODS: Subpleural perfusion was classified as poor (defined as subpleural spaces either not perfused or minimally perfused in all segments) or normal. We retrospectively reviewed PSP and hemodynamic variables of 101 consecutive patients who underwent BPA from February 2014 to August 2016. The total cross-sectional area of bronchial arteries was also measured by using CT scanning. Patients were categorized according to hemodynamic results after the last BPA: a failure group (defined as mean pulmonary arterial pressure > 30 mm Hg and a decrease in pulmonary vascular resistance < 30% [n = 15]) or a success group (n = 86).
RESULTS: Although baseline hemodynamic variables were similar between the two groups, PSP was observed in 46.7% of patients in the failure group vs 13.9% in the success group (P = .003). Multivariate analysis revealed that PSP was the only predictor of BPA failure (OR, 4.02 [95% CI, 1.17-13.89]; P = .028). Patients with PSP exhibited poorly developed bronchial arteries compared with patients with normal perfusion (7.0 [5.8-9.6] mm2 vs 8.7 [6.9-11.3] mm2; P = .032).
CONCLUSIONS: PSP in the capillary phase, suggesting the presence of small vessel disease with diffuse distal thrombosis, is a predictor of BPA failure. PSP was also associated with less developed bronchial arteries, which suggests a key role of bronchial-pulmonary anastomoses in maintaining the pulmonary capillary bed open downstream of the pulmonary arterial obstruction. PSP affected approximately 15% of patients with nonoperable CTEPH who underwent BPA.
Copyright © 2018 American College of Chest Physicians. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  balloon pulmonary angioplasty; chronic thromboembolic pulmonary hypertension; poor subpleural perfusion; predictive factor

Mesh:

Year:  2018        PMID: 29730328      PMCID: PMC6169450          DOI: 10.1016/j.chest.2018.03.059

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  33 in total

Review 1.  Vascular remodeling in the circulations of the lung.

Authors:  Wayne Mitzner; Elizabeth M Wagner
Journal:  J Appl Physiol (1985)       Date:  2004-11

Review 2.  Chronic thromboembolic pulmonary hypertension.

Authors:  Marius M Hoeper; Eckhard Mayer; Gérald Simonneau; Lewis J Rubin
Journal:  Circulation       Date:  2006-04-25       Impact factor: 29.690

3.  Predictors of residual pulmonary hypertension after balloon pulmonary angioplasty in patients with chronic thromboembolic pulmonary hypertension.

Authors:  Akihiro Tsuji; Takeshi Ogo; Jin Ueda; Shigefumi Fukui; Yoshiaki Morita; Tetsuya Fukuda; Norifumi Nakanishi; Hisao Ogawa; Satoshi Yasuda
Journal:  Int J Cardiol       Date:  2016-10-01       Impact factor: 4.164

4.  Microvascular disease in chronic thromboembolic pulmonary hypertension: a role for pulmonary veins and systemic vasculature.

Authors:  Peter Dorfmüller; Sven Günther; Maria-Rosa Ghigna; Vincent Thomas de Montpréville; David Boulate; Jean-François Paul; Xavier Jaïs; Benoit Decante; Gérald Simonneau; Philippe Dartevelle; Marc Humbert; Elie Fadel; Olaf Mercier
Journal:  Eur Respir J       Date:  2014-08-19       Impact factor: 16.671

5.  Chronic thromboembolic pulmonary hypertension (CTEPH): results from an international prospective registry.

Authors:  Joanna Pepke-Zaba; Marion Delcroix; Irene Lang; Eckhard Mayer; Pavel Jansa; David Ambroz; Carmen Treacy; Andrea M D'Armini; Marco Morsolini; Repke Snijder; Paul Bresser; Adam Torbicki; Bent Kristensen; Jerzy Lewczuk; Iveta Simkova; Joan A Barberà; Marc de Perrot; Marius M Hoeper; Sean Gaine; Rudolf Speich; Miguel A Gomez-Sanchez; Gabor Kovacs; Abdul Monem Hamid; Xavier Jaïs; Gérald Simonneau
Journal:  Circulation       Date:  2011-10-03       Impact factor: 29.690

Review 6.  The pathophysiology of chronic thromboembolic pulmonary hypertension.

Authors:  Gérald Simonneau; Adam Torbicki; Peter Dorfmüller; Nick Kim
Journal:  Eur Respir Rev       Date:  2017-03-29

Review 7.  The Pathobiology of Chronic Thromboembolic Pulmonary Hypertension.

Authors:  Irene M Lang; Peter Dorfmüller; Anton Vonk Noordegraaf
Journal:  Ann Am Thorac Soc       Date:  2016-07

8.  Diastolic pulmonary vascular pressure gradient: a predictor of prognosis in "out-of-proportion" pulmonary hypertension.

Authors:  Christian Gerges; Mario Gerges; Marie B Lang; Yuhui Zhang; Johannes Jakowitsch; Peter Probst; Gerald Maurer; Irene M Lang
Journal:  Chest       Date:  2013-03       Impact factor: 9.410

9.  Prognostic and pathophysiological marker for patients with chronic thromboembolic pulmonary hypertension: Usefulness of diffusing capacity for carbon monoxide at diagnosis.

Authors:  Rika Suda; Nobuhiro Tanabe; Keiichi Ishida; Fumiaki Kato; Takashi Urushibara; Ayumi Sekine; Rintaro Nishimura; Takayuki Jujo; Toshihiko Sugiura; Ayako Shigeta; Seiichiro Sakao; Koichiro Tatsumi
Journal:  Respirology       Date:  2016-09-11       Impact factor: 6.424

10.  Refined balloon pulmonary angioplasty for inoperable patients with chronic thromboembolic pulmonary hypertension.

Authors:  Hiroki Mizoguchi; Aiko Ogawa; Mitsuru Munemasa; Hiroshi Mikouchi; Hiroshi Ito; Hiromi Matsubara
Journal:  Circ Cardiovasc Interv       Date:  2012-11-27       Impact factor: 6.546

View more
  5 in total

Review 1.  Balloon pulmonary angioplasty for chronic thromboembolic pulmonary hypertension.

Authors:  Amanda Lloji; Urvashi Hooda; Jayakumar Sreenivasan; Ramin Malekan; Wilbert S Aronow; Gregg M Lanier
Journal:  Am J Cardiovasc Dis       Date:  2021-06-15

Review 2.  Balloon Pulmonary Angioplasty: State of the Art.

Authors:  John G Coghlan; Alexander Mk Rothman; Stephen P Hoole
Journal:  Interv Cardiol       Date:  2021-02-15

3.  Diffusing Capacity for Carbon Monoxide Predicts Response to Balloon Pulmonary Angioplasty in Patients With Inoperable Chronic Thromboembolic Pulmonary Hypertension.

Authors:  Xin Li; Yi Zhang; Qin Luo; Qing Zhao; Qixian Zeng; Tao Yang; Qi Jin; Lu Yan; Anqi Duan; Jiaran Liu; Chenhong An; Xiuping Ma; Changming Xiong; Zhihui Zhao; Zhihong Liu
Journal:  Front Cardiovasc Med       Date:  2021-12-02

4.  Heart-Rate Recovery at 1 Min After Exercise Predicts Response to Balloon Pulmonary Angioplasty in Patients With Inoperable Chronic Thromboembolic Pulmonary Hypertension.

Authors:  Yi Zhang; Xin Li; Qin Luo; Qing Zhao; Qixian Zeng; Tao Yang; Qi Jin; Lu Yan; Anqi Duan; Xiuping Ma; Chenhong An; Changming Xiong; Zhihui Zhao; Zhihong Liu
Journal:  Front Cardiovasc Med       Date:  2022-02-18

5.  Microvasculopathy Evaluated by Dual-Energy Computed Tomography in Patients with Chronic Thromboembolic Pulmonary Hypertension and Pulmonary Arterial Hypertension.

Authors:  Keisuke Miwa; Yu Taniguchi; Hiroyuki Fujii; Yoichiro Matsuoka; Hiroyuki Onishi; Kenichi Yanaka; Yu Izawa; Yasunori Tsuboi; Atsushi Kono; Noriaki Emoto; Kenichi Hirata
Journal:  Life (Basel)       Date:  2022-08-15
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.